In tumor cells, doxorubicin (DOX) is excreted by P-glycoprotein (P-gp) and
the multidrug resistance-associated protein (mrp). Both transporters might
also be involved in cellular regulatory volume decrease (RVD). To study the
hepatobiliary excretion of DOX during RVD, isolated livers of Wistar and m
ultidrug resistance-associated protein 2 (mrp2)deficient TR- rats were firs
t perfused with an isotonic and later with a hypotonic medium. In both rat
strains, DOX is effectively excreted into the bile. Within 30 minutes, the
biliary excretion of DOX-derived fluorescence steadily increased to 1.1 +/-
0.11 and 0.84 +/-0.05 nmoles/min. g liver in Wistar and TR- rats, respectiv
ely. Under hypotonic conditions, DOX excretion followed the biphasic-increa
se in bile flow. Excretion was increased to 136 +/- 19% and 176 +/-9% (firs
t peak) and to 141 +/- 11% and 157 +/- 14% (second peak) in Wistar and TR-
rats, respectively. Our data show that in the liver of both strains, exposu
re to a hypotonic medium stimulates DOX excretion, presumably by activation
of P-gp and mrp2 during RVD.